Cohort analysis reveals early risk factors for VA-ECMO in severe cardiotoxic poisoning cases, suggesting implications for urgent care strategies.
Key Points
Mortality and complications increased in patients receiving VA-ECMO for severe cardiotoxic poisoning, indicating higher clinical severity.
Overall, 16.4% of patients required VA-ECMO, with significant differences in outcomes compared to conventional treatment group.
Factors like low mean arterial pressure and hyperlactatemia were key predictors for VA-ECMO use at ICU admission, highlighting the need for careful monitoring.
The study's classification model achieved an accuracy of 91.1%, underlining the potential for identifying high-risk patients early.